In isolated blood vessels, acetylcholine releases endothelium-derived relaxing factor (EDRF). In vivo, the vasodilator action of acetylcholine may be mediated by EDRF, but prostacyclin or prejunctional inhibition of adrenergic neurotransmission may also be involved. Therefore, we investigated whether acetylcholine releases EDRF in humans in vivo and, if so, whether the response altered in essential hypertension. Acetylcholine was infused into the brachial artery, and forearm blood flow measured by venous occlusion plethysmography. In control subjects, acetylcholine (0.02-16 j,g/min/100 ml tissue) increased flow from 2.4±5.0 to 20.6±5.2 ml/min/100 ml tissue (n = 14; p <0.05) and decreased forearm vascular resistance from 42.0± 4.1 to 6.0+1.4 units (p<0.03), a response comparable to that of sodium nitroprusside (0.6 ,ug/min/100 ml tissue). Acetylsalicylic acid (500 mg i.v.) given to block vascular prostacyclin production did not alter the response (n=14). a-Adrenoceptor blockade by phentolamine (12 ,ug/min/100 ml tissue) did not prevent the increase in flow evoked by acetylcholine. In hypertensive patients, the decrease in forearm vascular resistance induced by acetylcholine but not evoked by sodium nitroprusside was reduced as compared with controls (14.5+±3.1 and 6.1+±1.6 units, respectively; n=8; p<0.05). Thus, the vascular effects of acetylcholine in the human forearm circulation are independent of prostaglandins and adrenergic neurotransmission and therefore are most likely to be mediated by EDRF; the acetylcholine- The study began at 8:00 AM and continued for approximately 4-5 hours. The subjects were supine in a quiet, air-conditioned room maintained at a constant temperature (20-22°C) . The forearm volume was measured by water displacement using the Archimedes principle, and drug doses were adjusted accordingly. Under local anesthesia (lidocaine 1%), an 18-gauge catheter (Abbocath-T, Abbott, Sligo, Ireland) was inserted into the left brachial artery for regional infusion of acetylcholine, sodium nitroprusside, and phentolamine and for the recording of arterial pressure with a Statham P23 Pb pressure transducer. The subjects were allowed to rest for 30 minutes after completion of instrumentation. Basal forearm blood flow and intra-arterial blood pressure were recorded, and sodium nitroprusside was infused at a concentration of 0.6 ,ug/min/100 ml forearm tissue for 2 minutes. In previous studies, this dose of intra-arterial sodium nitroprusside was found to pro- induced by increasing dosages of acetylcholine infused into the brachial artery of normal subjects. Forearm blood flow increased in a dose-dependent fashion from the lowest to the highest dose of acetylcholine compared with basal levels (p<O.O5).
was infused in 11 increasing dosages (0.02-16 ,ug/ min/100 ml forearm tissue) for 2-3 minutes with a constant-rate infusion pump (Sage Instruments Inc, New York). In eight normotensive subjects and six patients with essential hypertension, the infused volumes varied between 0.2 and 3.0 ml/min. For comparison of the eight normotensive and eight essential hypertensive, the volumes were held constant at 1 ml/min. After the dose-response curve to acetylcholine was completed, 500 mg acetylsalicylic acid (Aspegic) was infused intravenously during 20 minutes to inhibit the vascular production of prostacyclin. 4 
Vascular Effects ofAcetylcholine
In normotensive subjects, stepwise increasing intra-arterial dosages of acetylcholine (from 0.02 to 16 ,ug/min/100 ml forearm tissue) augmented forearm blood flow from 2.4+±0.5 to 20.6+±5.2 ml/min/100 ml forearm tissue (n = 14; p <0.05) (Figure 1 
Acetylcholine and Vascular Prostacyclin Production
No significant difference in the forearm hemodynamic response to acetylcholine were found before and after intravenous application of 0.5 g acetylsalicylic acid (Aspegic) to inhibit the formation of vascular prostaglandins. Forearm blood flow increased from 3.2±0.6 to 23.5±5.7 ml/min/100 ml forearm tissue, similar to control conditions (n = 14; p<0.05). FVR decreased from 34.4±4.0 to 6.1+1.4 units (n=14; p<0.02), and percent change of FVR increased from 20.2±3.8% to 83.2±3.2% (n=14; p<0.02) (Figure 2 ).
Acetylcholine and Sodium Nitroprusside
The increase in forearm blood flow and the decrease in vascular resistance evoked by a maximal dose of acetylcholine (16 ,ug/min/100 ml forearm tissue) were comparable to that induced by sodium nitroprusside (0.6 gg/min/100 ml forearm tissue) in the same subjects. Forearm blood flow after infusion of the maximal dose of acetylcholine and sodium nitroprusside was 20.6±5.2 and was 13.2±1.8 ml/ min/100 ml forearm tissue, (n = 14; NS). Accordingly, FVR during infusion of the highest dose of acetylcholine (6.3± 1.3 units) and during infusion of sodium nitroprusside (7.2±1.0 units) did not differ statistically (Figure 3 in the forearm circulation ofnormal subjects. Note the marked and comparable increase in forearm blood flow and reduction in forearm vascular resistance, respectively, during infusion of the maximal dose of acetylcholine (E ) and sodium nitroprusside ( z) in normal subjects.
response curve to the muscarinic agonist was performed in four healthy volunteers before and after blockade of a-adrenergic receptors by phentolamine.
Infusions of 0.3, 1, 4, and 16 ,ug/min/100 ml forearm tissue acetylcholine were applied alone and in combination with 12 ,ug/min/100 ml forearm tissue phentolamine in the same subjects. Phentolamine alone resulted in increase in forearm blood flow from 2.7±0.7 to 5.6±0.4 ml/min/100 ml forearm tissue (p<0.005). After intra-arterial infusion of acetylcholine alone, blood flow increased from 2.7+0.3 to 28.3±+10.1 ml/min/100 ml forearm tissue (p<0.05). During simultaneous infusion of phentolamine and acetylcholine, forearm blood flow increased from 5.6+0.2 to 53.1+10.5 ml/min/100 ml forearm tissue (p<0.02). Thus, adrenergic blockade did not prevent but instead augmented the vasodilator response to the muscarinic agonist. Accordingly, the percent change of blood flow (expressed as percentage of the corresponding maximal forearm blood flow) and the percent change of resistance did not differ significantly between the two infusion series (Figure 4 ).
Vascular Effects ofAcetylcholine in Hypertensive Subjects
Intra-arterial mean blood pressure averaged 83±3 mm Hg in normotensive subjects and 119±6 mm Hg in hypertensive patients and remained unchanged during the study (n=8, each group; p<0.001). Similarly, during the duration of the study, forearm blood flow did not change significantly in the control arm (data not shown). Intra-arterial infusions of increasing doses of acetylcholine (0.02-16 ,g/min/100 ml forearm tissue) induced dose-dependent increases in forearm blood flow from 2.5±0.8 to 24.1±6.6 ml/ min/100 ml forearm tissue (p<0.01) in the normotensive and from 3.1±0.3 to 13.7±3.8 ml/min/100 ml forearm tissue (p<0.02) in the hypertensive subjects. Accordingly, there was a dose-dependent . Bar graphs of changes in forearm blood flow in response to intra-arterially applied acetylcholine under control conditions (n) and after infusion ofphentolamine (n) in the foreartn circulation of normal subjects. Note the comparable percent increase in forearm blood flow in the presence and absence ofphentolamine to block the vascular effects of the sympathetic nervous system. These experiments exclude a major contribution of prejunctional muscarinic inhibition of sympathetic neurotransmission to the vasodilator effects of acetylcholine in vivo.
decrease in vascular resistance from 45.3 + 6.6 to 6.1±1.6 units (p<0.001) in normotensive subjects and from 41.4±4.3 to 14.5+3.1 units (p<0.001) in hypertensive patients. The absolute change in forearm vascular resistance evoked by higher dosages of acetylcholine were less pronounced in hypertensive patients than in control subjects (n=8, each group; p<0.05) ( Figure  5 ). prusside (0.6 gg/min/100 ml forearm tissue; 7.8--1.4 and 12.9±2.5 units, respectively) ( Figure 5 ).
Discussion
The present study provides indirect evidence for the release of EDRF in response to acetylcholine in resistance arteries of the human forearm circulation and demonstrates that this response is reduced in patients with uncomplicated essential hypertension.
That EDRF mediates the vasodilator actions of intra-arterially infused acetylcholine is based on the following observations ( Figure 6 ).
First, intravenous infusion of acetylsalicylic acid to inhibit the production of vascular prostaglandins4, [8] [9] [10] [11] 24 did not affect the increase in forearm blood flow observed during the infusion of the muscarinic agonist. Thus, a significant contribution of vascular prostaglandins to the vasodilator actions of acetylcholine in the human forearm in vivo can be excluded. Similar conclusions have been reached in isolated blood vessels of experimental animals and of humans. [4] [5] [6] [7] [8] [9] [10] [11] Second, an inhibition of adrenergic neurotransmission by acetylcholine-activating prejunctional muscarinic receptors has long been considered the main mechanism mediating the vascular effects of the 13 To exclude a contribution of prejunctional effects of acetylcholine, we compared the vasodilator action of the cholinergic neurotransmitter in the presence and absence of phentolamine to block postjunctional a-adrenergic receptors. Phentolamine alone increased blood flow, indicating effective blockade of a-adrenergic receptors in the forearm circulation.2025-27 Previous studies have shown that under these conditions, the effects of exogenous norepinephrine are inhibited.25 Thus, the effects of neurally released norepinephrine should be excluded. However, the vascular effects of acetylcholine were not prevented but instead augmented, leading to a comparable relative increase in forearm blood flow like under control conditions. Therefore, this suggests that the vascular effects of acetylcholine can not be attributed to an inhibitory action on sympathetic neurons or to a stimulation of vascular prostacyclin production. Thus, it is likely that -like in isolated human blood vessels obtained from the same vascular bed6 -intra-arterially applied acetylcholine activates muscarinic receptors on endothelial cells and evokes the release of EDRF. Indeed, in isolated mesenteric resistance arteries of the rat and in human subcutaneous resistance vessels, the relaxations evoked by acetylcholine are mediated by EDRF.36 39 Finally, in line with this interpretation, the potency of the response to acetylcholine was comparable to that induced by sodium nitroprusside. Sodium nitroprusside, like EDRF, evokes vascular relaxation by increasing cyclic guanosine-3',5'-monophosphate (cGMP) in vascular smooth muscle. 7, 10, [28] [29] [30] Thus, this study provides indirect evidence for the release of EDRF in resistance arteries of the human forearm circulation in vivo. Hence, EDRF may not only modulate vascular tone of large conduit arteries31,32 and veins in vivo33 but may also contribute to the regulation of resistance arteries where local blood flow is regulated. That inhibition of the Larginine pathway increases blood pressure in experimental animals34 and decreases local blood flow in humans35 is consistent with that interpretation.
In experimental animals, chronic hypertension is associated with attenuated endothelium-dependent relaxations to acetylcholine.1012-17,36-39 The impairment of endothelial function occurring in hypertension is closely correlated with the degree of hypertension and can be reversed by antihypertensive therapy. 10, 15, 40 We have compared the vasodilator action of acetylcholine in normal subjects and in patients with uncomplicated essential hypertension. In the hypertensive group, the reduction in FVR in response to acetylcholine was significantly less pronounced than that of normotensive control subjects. In contrast, the maximal response to sodium nitroprusside did not differ between the two groups, suggesting that an altered endothelial release of EDRF rather than a decreased responsiveness of vascular smooth muscle cells to the factor is involved. As in experimental hypertension, the difference between normotensives and hypertensives was particularly pronounced at higher concentrations of acetylcholine.1012- 17 That alterations in endothelial function occur in the forearm of patients with uncomplicated essential hypertension is particularly striking because this part of the circulation rarely develops hypertensive vascular disease. Thus, vascular beds such as the coronary, cerebral, renal, and limb circulation,41 which are known targets of hypertension, may exhibit much more pronounced changes in endothelial function. Indeed, in isolated human coronary arteries obtained from patients with coronary artery disease, the release of EDRF is severelv reduced.7,9
